Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Samsung Electronics (005930) – Kiwoom Securities | Upward Memory ASP Revisions · FY26 Operating Profit Raised to KRW 170T · HBM4 Pricing Leverage / 2026-01-23 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Order Recovery · Plant Ramp-up · Earnings Growth / 2026-07-24 Research
  • [IR] Samsung Electronics (005930) – Q1 2026 Earnings Presentation / 2026-04-30 IR Room
  • [Research] Samsung Biologics (207940) – Daishin Securities | Plant 5 Operation · Fixed-Cost Operating Leverage · Plant 6 Expansion / 2026-05-19 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | ROE Expansion · Net Cash · Shareholder Returns / 2026-07-29 Research
  • [Research] Samsung Electronics (005930) – Hana Securities | Unprecedented Memory ASP Surge · 4Q25 Earnings Beat · Meaningful FY26 Forecast Upgrades / 2026-01-09 Research
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | MLCC LTA Demand · Substrate Expansion · Product Mix / 2026-01-26 Research
  • [Research] Samsung SDI (006400) – iM Securities | Surging AIDC ESS Demand · US Regulatory Tailwinds · Valuation Assessment / 2026-04-29 Research

[Research] Samsung Electronics (005930) – Mirae Asset Securities | Operating Leverage · LTA Price Bands · High ROE Sustainability / 2026-04-06

Posted on 4월 6, 20268월 25, 2026 By ksb220805@gmail.com

Brokerage : Mirae Asset Securities

Analyst : Young-gun Kim

Investment Rating : Buy (Maintained)

Target Price : KRW 300,000 (Maintained)

Core Momentum : Operating leverage driven by DRAM ASP hikes and lower cash costs, combined with expectations that an ROE of at least 30% can be sustained if LTA price bands hold even as price increases moderate, underpins strong earnings visibility.

📊 1. [Valuation & Key Financial Metrics]

  • Investment Rating & Target Price: Buy maintained, Target Price maintained at KRW 300,000 (61.1% upside potential based on the April 3, 2026 closing price of KRW 186,200)
  • Valuation Methodology: Sum-of-the-Parts (SOTP) valuation applied (Operating Value KRW 1,865.5T + Equity Value KRW 106.5T + Net Cash KRW 104.2T, yielding a Target Market Cap of KRW 2,013T)
  • Key Valuation Multiples (2026F): P/E 5.4x, P/B 1.9x, ROE 42.8%, Dividend Yield 4.7%
  • Per-Share Metrics (2026F): EPS KRW 34,316 (2027F EPS KRW 46,291, 2028F EPS KRW 50,529; BPS not specified in summary table)
  • Annual Financial Projections:
    • 2024: Revenue KRW 300.87T, Operating Profit KRW 32.73T, Net Profit (Controlling) KRW 33.62T
    • 2025: Revenue KRW 333.61T, Operating Profit KRW 43.60T, Net Profit (Controlling) KRW 44.26T
    • 2026F: Revenue KRW 627.97T, Operating Profit KRW 303.96T (exceeding consensus of KRW 211.41T, OPM 48.4%), Net Profit (Controlling) KRW 231.14T
    • 2027F: Revenue KRW 763.17T, Operating Profit KRW 399.27T (OPM 52.3%), Net Profit (Controlling) KRW 311.80T
    • 2028F: Revenue KRW 814.62T, Operating Profit KRW 406.62T (OPM 49.9%), Net Profit (Controlling) KRW 340.34T

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Earnings Preview:
    • Projected Operating Profit raised by 13.2% to KRW 46.8T (DS KRW 42.6T, DX KRW 3.6T, etc.)
    • DRAM Metrics Upgrade: DRAM blended ASP growth revised up to 64.0% (+8.6%pt from 55.4%); cash cost assumption lowered, lifting DRAM OPM estimate to 73% (+16%pt QoQ)
    • Operating Leverage: Period to observe the maximization of operating leverage via advanced node yield stabilization and product mix amid capacity/inventory constraints
  • 2Q26 Growth Catalysts:
    • Low bit growth (B/g) with high ASP in 1Q indicates customers failed to secure sufficient volumes; 2Q is expected to see simultaneous shipment growth and price increases
  • LTA Structure & Industry Landscape:
    • Expansion of 3-year-plus Long-Term Agreements (LTAs) with Big Tech (focus on securing volume, upfront cash deposits, quarterly price renegotiations to adjust collateral ratios)
    • Contracts incorporate price fluctuation bands (caps/floors) with collateral volume adjustments if market prices deviate
    • Increased proportion of long-term contract clients reduces market share competition among suppliers across the broader industry

📝 Editor’s Comment (Perspective)

The analyst views Samsung Electronics not as a cyclical vendor dependent solely on short-term price momentum, but as an enterprise undergoing structural improvements capable of sustaining an ROE of at least 30% if LTA price bands are maintained, supported by operating leverage from advanced node yield stabilization and product mix optimization. This perspective places primary significance on cash cost reductions, operating leverage, and reduced market share competition via LTA structures, rather than market concerns regarding the potential moderation of price increase rates.

To verify whether this investment thesis continues to materialize, key verification points include whether 2Q delivers simultaneous shipment growth and price increases to sustain operating leverage, whether advanced node yield stabilization translates into product mix optimization, and whether maintaining LTA price bands effectively sustains ROE levels above 30%. These factors can be monitored through upcoming quarterly earnings announcements, official IR materials, regulatory filings, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

글 탐색

Previous Post: [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | FC-BGA · MLCC · Price Increase / 2026-04-06
Next Post: [Research] Samsung Electronics (005930) – Shinhan Securities | Memory Pricing Elasticity · Operating Leverage · Shareholder Return Expectations / 2026-04-06

Related Posts

  • [Research] Celltrion (068270) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07 Research
  • [Research] Alteogen (196170) – Daishin Securities | Key US Patent Risks Significantly Eased · New Licensing Catalysts · Keytruda SC Milestones / 2026-06-02 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | Dual Up-cycle · Large-Scale CapEx · Target Price Upgrade / 2026-07-08 Research
  • [Research] Samsung SDI (006400) – Hana Securities | SDC Stake Monetization Pursuit · Up to KRW 11T Liquidity · Valuation Multiples Re-rating / 2026-02-20 Research
  • [Research] Alteogen (196170) – Hana Securities | ALT-B4 Differentiation Potential · Enhanze Biosimilar Concerns Dispelled · Qlex Revenue Visibility / 2026-07-15 Research
  • [Research] KEPCO (015760 / KEP) – Shinhan Securities | 15-Year High Nuclear Utilization · SMP Decline · US-Korea Nuclear Agreement / 2026-01-26 Research
  • [Research] Samsung Electronics (005930) – Mirae Asset Securities | Memory Pricing Strength · Earnings Upward Revision · High ROE Sustainability / 2026-03-23 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI Demand · Supply Tightness · Margin Expansion / 2026-08-11 Research
  • [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28 Research
  • [Research] Samsung Electronics (005930) – Shinhan | Memory Excess Demand · DS Earnings Surge · Shareholder Return Expectations / 2026-04-21 Research
  • [Research] Samsung Electronics (005930) – Mirae Asset | Foundry Value Upgrade · Advanced Node Wins · HBM Revenue Surge / 2026-05-07 Research
  • [Research] Samsung Biologics (207940) – iM Securities | New Plant Operations · PolyPeptide Acquisition · Portfolio Diversification / 2026-07-24 Research
  • [Research] Samsung SDI (006400) – DS Investment & Securities | ESS Revenue Surge · 4Q26 Turnaround · Physical AI Expansion with 46-Series & All-Solid-State / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · LTA · Supply Tightness / 2026-04-23 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme